# Administration of Intravenous Vitamin C in Novel Coronavirus Infection (COVID-19) and Decreased Oxygenation

> **NCT04357782** · PHASE1,PHASE2 · COMPLETED · sponsor: **Hunter Holmes Mcguire Veteran Affairs Medical Center** · enrollment: 20 (actual)

## Conditions studied

- COVID-19
- Hypoxia

## Interventions

- **DRUG:** L-ascorbic acid

## Key facts

- **NCT ID:** NCT04357782
- **Lead sponsor:** Hunter Holmes Mcguire Veteran Affairs Medical Center
- **Sponsor class:** FED
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-04-16
- **Primary completion:** 2020-10-13
- **Final completion:** 2020-10-13
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2022-02-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04357782

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04357782, "Administration of Intravenous Vitamin C in Novel Coronavirus Infection (COVID-19) and Decreased Oxygenation". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04357782. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*